Norris Cotton Cancer Center
About Us News & Events Careers How to Help
Patient Care For Patients & Visitors For Cancer Professionals Cancer Research Clinical Trials Regional Locations
Search

Alan Charles Hartford MD, PhD

Contact Information:
Phone: (603) 650-6600
Fax: (603) 650-6616
Email: not given

Institution Affiliations:
Dartmouth-Hitchcock Medical Center, Lebanon
Assistant Professor of Radiation Oncology
Section: Radiation Oncology
Specialty: Radiation Oncology
Joined Staff: 2004

Cancer Center Membership:
Section of Radiation Oncology
Head and Neck Clinical Oncology Group
Comprehensive Thoracic Clinical Oncology Group
Neuro-Oncology Clinical Oncology Group
Genitourinary / Prostate Clinical Oncology Group

Clinical Interests:
Prostate and bladder cancers
Tumors of the brain and central nervous system
Advanced targeting of tumors in the chest and head-and-neck regions
Board Certified:
Medicine 1996
Radiation Oncology 1999
Degree(s): MD, PhD
S.B. (With Distinction) Stanford University Biology 1983
A.M. Stanford University Philosophy 1983
M.D. Harvard Medical School 1992
Ph.D. Harvard University Political Economy & Government 1997

Internship(s):
1992-93, New England Deaconess Hospital

Residency:
1993-98, Radiation Oncology, Massachusetts General Hospital

Fellowship(s):
1998, Radiation Oncology, Massachusetts General Hospital

Biography:

Research Interests:
Clinical outcomes and quality of life studies
The roles of oxygenation in radiation response and tissue healing

Selected Publications:
Hosek S, Anderson M, Hartford AC, Olson G, Press J, Sloss E. Plan for an evaluation of the CHAMPUS reform initiative. Santa Monica, California: The RAND Corporation; 1987 Jul. Report No.: N-2647-HA.
Budach W, Hartford AC, Gioioso D, Freeman J, Taghian A, Suit H. Tumors arising in SCID mice share enhanced radiation sensitivity of SCID normal tissues. Cancer Research 1992; 52:6292-6.
Gerweck L, Dulea R, Zaidi T, Budach W, Hartford AC. Influence of experimental factors on intrinsic radiosensitivity assays at low doses of radiation: cell multiplicity. Radiation Research 1994; 138:361-6.
Hartford AC, Niemierko A, Adams J, Urie M, Shipley WU. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. International Journal of Radiation Oncology, Biology, Physics 1996; 36:721-30.
Nozue M, Lee I, Hartford AC, Tanda S, Suit HD, Jain RK. pO2 measurement in murine tumors by Eppendorf "Histograph." International Journal of Oncology 1996; 9:955-62.
Council on Ethical and Judicial Affairs, American Medical Association. Medical futility in end-of-life care. JAMA 1999; 281:937-41.
Hartford AC, Gohongi T, Fukumura D, Jain RK. Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Research, Advances in Brief 2000; 60:2128-31.
Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK.. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nature Medicine 2004; 10:145-7.
  

NCI Logo